ASLTY (Asymchem Laboratories Tianjin Co) Accounts Payable & Accrued Expense: $232.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASLTY Asymchem Laboratories Tianjin Co Ltd ASLTY
69 GF Score
Price $8.15
GF Value $4.91
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense?

Asymchem Laboratories Tianjin Co ASLTY +9.40% 69 Accounts Payable & Accrued Expense is $232.7 Mil as of Mar. 2026. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $4.91 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Asymchem Laboratories Tianjin Co's quarterly accounts payable & accrued expense increased from Sep. 2025 ($202.6 Mil) to Dec. 2025 ($234.9 Mil) but then declined from Dec. 2025 ($234.9 Mil) to Mar. 2026 ($232.7 Mil).

Asymchem Laboratories Tianjin Co's annual accounts payable & accrued expense declined from Dec. 2023 ($215.5 Mil) to Dec. 2024 ($191.9 Mil) but then increased from Dec. 2024 ($191.9 Mil) to Dec. 2025 ($234.9 Mil).

Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Asymchem Laboratories Tianjin Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 263.73 268.40 215.49 191.89 234.90

Asymchem Laboratories Tianjin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.16 227.65 202.61 234.90 232.67
ASLTY
69GF Score
Asymchem Laboratories Tianjin Co Ltd ASLTY
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $232.7 Mil mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a Accounts Payable & Accrued Expense of $232.7 Mil as of Mar. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Asymchem Laboratories Tianjin Co and its competitors.
Is Asymchem Laboratories Tianjin Co's Accounts Payable & Accrued Expense too high?
Asymchem Laboratories Tianjin Co's current Accounts Payable & Accrued Expense is $232.7 Mil. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Accounts Payable & Accrued Expense compare to VRTX and REGN?
Asymchem Laboratories Tianjin Co's Accounts Payable & Accrued Expense of $232.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Biotechnology company?
A good Accounts Payable & Accrued Expense depends on the Biotechnology industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current Accounts Payable & Accrued Expense is $232.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.91, compared to a current price of $8.15 — trading 66% above its estimated fair value. The current Accounts Payable & Accrued Expense is $232.7 Mil. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Accounts Payable & Accrued Expense is $232.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of $8.15 is trading 66% above its estimated GF Value™ of $4.91. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for ASLTY:

  • Accounts Payable & Accrued Expense: $232.7 Mil
  • GF Value™: $4.91 vs. price of $8.15 (66% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Asymchem Laboratories Tianjin Co Business Description

Other Exchanges 06821:Hong Kong002821:China
Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score

Get the complete analysis for ASLTY

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.15
Price
$4.91
GF Value